VCNX - Vaccinex, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
90.41M
Enterprise Value 3
90.32M
Trailing P/E
N/A
Forward P/E 1
-2.03
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
176.93
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
176.75
Enterprise Value/EBITDA 6
-2.76

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-22.70%
S&P500 52-Week Change 313.40%
52 Week High 38.49
52 Week Low 33.32
50-Day Moving Average 36.11
200-Day Moving Average 35.77

Share Statistics

Avg Vol (3 month) 35.12k
Avg Vol (10 day) 33.18k
Shares Outstanding 514.86M
Float 3.05M
% Held by Insiders 184.78%
% Held by Institutions 12.14%
Shares Short (Oct 15, 2019) 462.58k
Short Ratio (Oct 15, 2019) 46.75
Short % of Float (Oct 15, 2019) 42.74%
Short % of Shares Outstanding (Oct 15, 2019) 40.42%
Shares Short (prior month Sep 13, 2019) 418.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,460.47%

Management Effectiveness

Return on Assets (ttm)-348.65%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)511k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-80.20%
Gross Profit (ttm)-309k
EBITDA -32.78M
Net Income Avi to Common (ttm)-31.35M
Diluted EPS (ttm)-3.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.28M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.69
Book Value Per Share (mrq)-2.30

Cash Flow Statement

Operating Cash Flow (ttm)-29.2M
Levered Free Cash Flow (ttm)-18.58M